Law360, New York (November 10, 2008) -- A California appellate court has said makers of brand-name drugs can be held responsible for failing to warn of side effects suffered by those taking the generic equivalents of their medications.
The First District Court of Appeals in San Francisco on Friday reinstated a case Elizabeth Conte brought against Wyeth alleging the generic version of the anti-heartburn medication Reglan caused her...
